What is the interaction between buspirone and hydroxide in a patient taking methamphetamine (meth)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Buspirone should be used with caution in patients taking methamphetamine, and its interaction with hydroxide is not well-studied, but it is known that buspirone can be affected by various drug interactions, including those with substances that alter its metabolism or increase the risk of serotonin syndrome 1. When considering the use of buspirone in a patient taking methamphetamine, it's crucial to prioritize the patient's safety and monitor for potential interactions.

  • Buspirone is an anxiolytic medication that works on serotonin receptors and may help manage anxiety symptoms that can occur during methamphetamine withdrawal or recovery.
  • The typical starting dose is 5 mg three times daily, which can be gradually increased to 20-30 mg daily in divided doses.
  • However, buspirone should not be combined with hydroxide preparations without specific medical guidance, as this combination is not well-studied and may increase the risk of adverse effects.
  • If the patient is actively using methamphetamine, there is potential for complex drug interactions that could affect the central nervous system.
  • Buspirone takes 2-4 weeks to reach full therapeutic effect, so it's not useful for acute anxiety relief.
  • For patients with methamphetamine use disorder, comprehensive treatment should include behavioral therapy alongside any medication.
  • Medical supervision is essential as methamphetamine can cause cardiovascular complications, and any medication regimen should be carefully monitored.
  • Patients should be honest about their substance use with healthcare providers to prevent dangerous drug interactions and ensure appropriate treatment. According to a recent study, high-dose buspirone (30 mg) can be used in combination with meperidine to reduce the threshold for shivering responses, but caution is advised for those at risk of seizure or those who are not continuously monitored 1. It's also important to note that buspirone can be affected by various drug interactions, including those with substances that alter its metabolism or increase the risk of serotonin syndrome, as reported in a study on drug-drug interactions involving rifamycins 1. Overall, the use of buspirone in patients taking methamphetamine requires careful consideration of potential interactions and close monitoring to ensure safe and effective treatment.

From the Research

Interaction between Buspirone and Hydroxide in a Patient taking Methamphetamine

  • There are no direct studies on the interaction between buspirone and hydroxide in a patient taking methamphetamine.
  • However, a study on the effects of acute buspirone treatment on the subjective and cardiovascular effects of oral methamphetamine found that buspirone increased some of the abuse-related subjective effects of methamphetamine 2.
  • Buspirone's mechanism of action is complex, but its main neuropharmacologic effects are mediated by the 5-HT1A receptors, which may interact with other neurotransmitter systems 3, 4.
  • The combination of oral methamphetamine and buspirone was found to be safe and well tolerated in a study, but acute buspirone administration may increase the abuse liability of oral methamphetamine 2.
  • There is no information available on the specific interaction between buspirone and hydroxide in the context of methamphetamine use.
  • Buspirone has been studied in various contexts, including the treatment of generalized anxiety disorder, and has been found to be effective and well tolerated 5, 3, 4, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Buspirone, a new approach to the treatment of anxiety.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.